Advanced Biomed ADVB
NASDAQ ADVB
$6.96 +0.73 (+11.72%)
As of: Oct 1, 2026 · 12:36 PM EDT

Advanced Biomed (ADVB) Long-Term Debt Repayments (2025)

Updated

Advanced Biomed (ADVB) posted Long-Term Debt Repayments of $6,715 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 40.2% from the prior quarter.

Analysis

Advanced Biomed (ADVB) Long-Term Debt Repayments (2025) Analysis & Trends

For the trailing twelve months through Dec 31, 2025, Long-Term Debt Repayments at Advanced Biomed was $853,240; for FY2025 (ended Jun 30, 2025), it was $837,552.

  • Quarterly Long-Term Debt Repayments has run from a low of -$1,069 in fiscal Q3 2025 to a high of $836,368 in fiscal Q4 2025 over five years.
  • According to Business Quant data, Long-Term Debt Repayments for the three prior fiscal quarters was $11,226 (Q1 2026), $836,368 (Q4 2025) and -$1,069 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 1.41 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 2.00 Bn
10 Advanced Biomed 8.61 Mn 8.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6,715.00
Sep 30, 2025 11,226.00
Jun 30, 2025 836,368.00
Mar 31, 2025 -1,069.00
API Access

Advanced Biomed Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ADVB&period=max&api_key=YOUR_API_KEY